TESSA Technology: A Plasmid Free, Scalable System to Transform AAV Manufacture

Поделиться
HTML-код
  • Опубликовано: 7 сен 2024
  • "TESSA Technology: A Plasmid Free, Scalable System to Transform AAV Manufacture." Presented by Weiheng Su, Principal Scientist, OXGENE, A WuXi Advanced Therapies Company.
    BioProcess International Ask the Expert 2021.

Комментарии •